Invention Grant
- Patent Title: Use of Lactobacillus casei for increasing the protection provided by the influenza vaccine
- Patent Title (中): 使用干酪乳杆菌增加流感疫苗提供的保护
-
Application No.: US12527214Application Date: 2008-02-13
-
Publication No.: US08349315B2Publication Date: 2013-01-08
- Inventor: Sandrine Samson-Villeger , Raphaëlle Bourdet-Sicard
- Applicant: Sandrine Samson-Villeger , Raphaëlle Bourdet-Sicard
- Applicant Address: FR Paris
- Assignee: Compagnie Gervais Danone
- Current Assignee: Compagnie Gervais Danone
- Current Assignee Address: FR Paris
- Agency: Morgan, Lewis & Bockius LLP
- Priority: FR0701140 20070216
- International Application: PCT/FR2008/000181 WO 20080213
- International Announcement: WO2008/129148 WO 20081030
- Main IPC: A01N63/00
- IPC: A01N63/00
Abstract:
The invention relates to the use of Lactobacillus casei in orally administrable compositions for increasing protection against influenza after the influenza vaccine, by potentiating the humoral response generated by said vaccine.
Public/Granted literature
- US20100129334A1 Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine Public/Granted day:2010-05-27
Information query
